EVENTS & PRESS
EVENTS
〰️
EVENTS 〰️
November 9th, 2024
K.C. Psychedelic Freedom Conference
Dr. Ziemer presented on psychedelic courses in higher education based on her experience as a professor at two colleges designing curriculum and instructing on many aspects of psychedelics. She shared her knowledge as a leader in the Psychedelic Educators Network. Dr. Ziemer compared her work in undergraduate instruction to the standards of the American Psychological Association for post doctoral level training for psychedelic assisted therapy.
October 26th, 2024
St. Louis Psychedelic Freedom Conference
Dr. Bhatt spoke in front of an audience of aspiring clinicians seeking to learn more about the pharmacology of psychedelic molecules, like psilocybin. He expanded to provide a comprehensive overview on how these molecules work in the human body. His overview provided clarity on the language used in the recent Missouri Senate bill for providing access to medical psilocybin to veterans.
October 26th, 2024
St. Louis Psychedelic Freedom Conference
Dr. Fox gave a presentation at the Psychedelic Missouri conference entitled "The FDA Rejected MDMA Therapy, Now What?' Using her years of experience as a clinician and educator in mental health, Dr. Fox discussed other treatment modalities, including ketamine and traditional talk therapy, and provided her insights on the direction of psychedelic assisted therapy going forward.
October 26th, 2024
St. Louis Psychedelic Freedom Conference
Dr. Ziemer presented on psychedelic courses in higher education based on her experience as a professor at two colleges designing curriculum and instructing on many aspects of psychedelics. She shared her knowledge as a leader in the Psychedelic Educators Network. Dr. Ziemer compared her work in undergraduate instruction to the standards of the American Psychological Association for post doctoral level training for psychedelic assisted therapy.
October 26th, 2024
St. Louis Psychedelic Freedom Conference
Anne Bethune presented on the components of a comprehensive training program for licensed medical and mental health clinicians to provide psychedelic assisted therapy. This presentation was based on language in psilocybin bills proposed in the Missouri legislature as well as the research and precedent of the training and credentials required by the FDA for clinicians to work as facilitators on psychedelic clinical trials. Anne also shared her experience with developing proficiencies to work as a lead facilitator on Phase 1, 2 and 3 clinical trials for psychedelic study drugs.
October 3rd - 6th, 2024
PhilaDelic Conference, University Pennsylvani
Dr. Ziemer presented at the PhilaDelic Conference at the University of Pennsylvania discussing her leadership with Psychedelic Educators Network and the future of psychedelic coursework and in academia.
Specialized Courses for Licensed Professionals in Missouri, focused on Psilocybin-Assisted Psychotherapy
At Midwest Psychedelic, we are committed to empowering mental health and medical professionals with the knowledge and skills to safely, ethically, and effectively practice psychedelic-assisted therapy. Our comprehensive training program is designed specifically for licensed professionals, offering both synchronous and asynchronous content to fit into your busy schedule.
Training Mental Health Practitioners to Provide Psilocybin Assisted Psychotherapy
Our team has depth and expertise in pharmacology, medicine, psychedelic research and clinical trials, psychotherapy, psychedelic facilitation, psychiatric nursing, as well as a deep respect the historical use of plant medicines. This training program covers all aspects of working with psilocybin to address mental health concerns. You will learn how to safely, ethically and effectively use psilocybin in your clinical practice.
Learning modules will be synchronous and asynchronous. Training cohorts will be limited in size to ensure a quality learning experience.
End of Life: Psychedelic Assisted Therapy using psilocybin has been shown to increase quality of life and death acceptance for those facing life limiting illnesses.